Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Kunio Asonuma

6PUBLICATIONS
18CO-AUTHORS
Industrial microbiology (incl. biofeedstocks)Immunogenetics (incl. genetic immunology)Molecular targetsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jun 09, 2025
Editorial: Time to EXIT? When Less Is More in IBD Management.

Kunio Asonuma, Taku Kobayashi

|Dec 06, 2024
Leucine-Rich Alpha-2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease.

Moeko Komatsu, Shintaro Sagami, Aya Hojo

|Nov 13, 2024
Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study.

Akira Nogami, Kunio Asonuma, Shinji Okabayashi

|Mar 25, 2024
Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights.

Kunio Asonuma, Shintaro Sagami, Taku Kobayashi

|Oct 12, 2023
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study.

Kunio Asonuma, Keiji Ozeki, Hajime Yamazaki

|Sep 28, 2023
Letter: Transperineal ultrasonography for ulcerative proctitis-Applicability in the pregnant population? Authors' reply.

Shintaro Sagami, Aya Hojo, Kunio Asonuma

Pageof 1

Frequent Collaborators

6 joint publications

Taku Kobayashi

2 joint publications

Shinichiro Shinzaki

2 joint publications

Shintaro Sagami

2 joint publications

Takahisa Matsuda

1 joint publications

Keiji Ozeki

1 joint publications

Hajime Yamazaki

1 joint publications

Soh Okano

1 joint publications

Hiroki Kiyohara

1 joint publications

Akira Andoh

1 joint publications

Akira Nogami

Frequent Collaborators

6 joint publications

Taku Kobayashi

2 joint publications

Shinichiro Shinzaki

2 joint publications

Shintaro Sagami

2 joint publications

Takahisa Matsuda

Top Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on : Jan 05, 2017

12.4K
Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on : Dec 15, 2017

8.2K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

995
See more related videos

Top Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on : Jan 05, 2017

12.4K
Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on : Dec 15, 2017

8.2K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

995
See more related videos